Authors

  • Юнусова З.Д., Ассесорова Ю.Ю., Исламов М.С., Мустафина Л.К., Алимов Т.Р., Бобоев К.Т., Марданов А.К., Латипова Н.Р., Бергер И.В., Жуламанова Д.И.

Keywords:

миелодиспластический синдром, del(5q), цитогенетическое исследование, редкие хромосомные нарушения, острый миелоидный лейкоз.

References

Auger N, Douet–Guilbert N, Quessada J, et al. Cytogenetics in the management of myelodysplastic neoplasms (myelodysplastic syndromes, MDS): Guidelines from the groupe francophone de cytogénétique hématologique (GFCH). Curr Res Transl Med. 2023 Oct–Dec; 71(4):1 03409. doi: 10.1016/j.retram. 2023.103409.

Bacher U, Schanz J, Braulke F, Haase D. Rare cytogenetic abnormalities in myelodysplastic syndromes. Mediterr J Hematol Infect Dis. 2015 May 1;7(1):e2015034. doi: 10.4084/MJHID.2015.034.

da Silva–Coelho P, Kroeze LI, Yoshida K, et al. Clonal evolution in myelodysplastic syndromes. Nat Commun. 2017 Apr 21; 8:1 5099. doi: 10.1038/ ncomms15099.

Dodillet H, Kreuzer KA, Monsef I, Skoetz N. Thrombopoietin mimetics for patients with myelodysplastic syndromes. Cochrane Database Syst Rev. 2017 Sep 30; 9(9): CD009883. doi: 10.1002/14651 858.CD009883.pub2.

Fenaux P, Haase D, Santini V, et al. ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Myelodysplastic syndromes: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow–up†☆. Ann Oncol. 2021 Feb; 32(2): 142–156. doi: 10.1016/j.annonc.2020.11.002.

Garcia–Manero G. Myelodysplastic syndromes: 2023 update on diagnosis, risk–stratification, and management. Am J Hematol. 2023 Aug; 98(8): 1307–1325. doi: 10.1002/ajh.26984. Epub 2023 Jun 8. PMID: 37288607.

Karel D, Valburg C, Woddor N, Nava VE, Aggarwal A. Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape. Curr Oncol. 2024 Apr 3;31(4):1971–1993. doi: 10.3390/curroncol31040148.

McGowan–Jordan J., Simons A., Schmid M. ISCN: An international system for human cytogenomic nomenclature. Basel, New York: Karger; 2016. – 140 p.

Muto T, Walker CS, Agarwal P, et al. Inactivation of p53 provides a competitive advantage to del(5q) myelodysplastic syndrome hematopoietic stem cells during inflammation. Haematologica. 2023 Oct 1;108(10):2715–2729. doi: 10.3324/haematol.2022.282349.

Nachtkamp K, Kobbe G, Gattermann N, Germing U. Myelodysplastic Syndromes: New Methods of Diagnosis, Prognostication, and Treatment. Dtsch Arztebl Int. 2023 Mar 24;120(12):203–210. doi: 10.3238/arztebl.m2023.0005.

Sekeres MA, Taylor J. Diagnosis and Treatment of Myelodysplastic Syndromes: A Review. JAMA. 2022 Sep 6;328(9):872–880. doi: 10.1001/ jama. 2022.14578.

Shao H, Cen J, Chen S, et al. Myeloid neoplasms with t(12;22)(p13;q12)/MN1–EVT6: a systematic review of 12 cases. Ann Hematol. 2018 Mar; 97(3):417–424. doi: 10.1007/s00277–017–3208–2. Epub 2017 Dec 22. PMID: 29273914.

Shao H, Yang Q, Gong Y, et al. [Molecular cytogenetic characterization of five patients with myeloid leukemia and t(12;22)(p13;q12)]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2019 Feb 10; 36(2): 112–115. Chinese. doi: 10.3760/cma.j.issn.1003–9406.2019.02.004.

Swerdlow S.H., Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon, France: International Agency for Research in Cancer (IARC) / ed. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H T.J. 2017. 585 p.

Vu MP, Ha HQ, Nguyen CN. Cytogenetic characteristics in Vietnamese patients diagnosed with primary myelodysplastic syndromes. Leuk Res Rep. 2022 Aug 12;18:100343. doi: 10.1016/j.lrr. 2022.100343.

Wu J, Zhang Y, Qin T, et al. IPSS–M has greater survival predictive accuracy compared with IPSS–R in persons ≥ 60 years with myelodysplastic syndromes. Exp Hematol Oncol. 2022 Oct 17; 11(1) :73. doi: 10.1186/s40164–022–00328–4.

Yang L, Qian Y, Eksioglu E, et al. The inflammatory microenvironment in MDS. Cell Mol Life Sci. 2015 May;72(10):1959–66. doi: 10.1007/s000 18–015–1846–x.

Zahid MF, Malik UA, Sohail M, et al. Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview. Int J Hematol Oncol Stem Cell Res. 2017 Jul 1;11(3):231–239.